(UTHR) United Therapeutics complete technical analysis [charts+indicators] | Buy/Sell United Therapeutics | (UTHR) share price targets
Complete technical analysis of United Therapeutics (UTHR) by charts plus indicators, forecast predictions and share price targets for United Therapeutics (UTHR)
United Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-06 View latest technical analysis
10 day averaged volume of United Therapeutics is 316000
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Thu Feb 2025 | 353.75 | 355.93 | 356.57 | 351.29 | 1.476 times |
| 05 Wed Feb 2025 | 354.18 | 348.21 | 358.87 | 348.21 | 1.222 times |
| 04 Tue Feb 2025 | 353.43 | 353.10 | 355.77 | 348.52 | 0.987 times |
| 03 Mon Feb 2025 | 354.58 | 348.17 | 358.63 | 344.36 | 1.168 times |
| 31 Fri Jan 2025 | 351.17 | 355.18 | 357.31 | 350.02 | 1.312 times |
| 30 Thu Jan 2025 | 352.30 | 370.00 | 370.40 | 349.07 | 1.585 times |
| 29 Wed Jan 2025 | 372.75 | 373.00 | 378.52 | 370.20 | 0.536 times |
| 28 Tue Jan 2025 | 370.85 | 370.99 | 382.61 | 368.02 | 1.013 times |
| 27 Mon Jan 2025 | 369.56 | 369.82 | 375.35 | 368.52 | 0.778 times |
| 24 Fri Jan 2025 | 370.83 | 372.73 | 375.61 | 365.88 | 0.628 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 355.4, but if it comes above 355.4, then a intra day buy could be more profitable.
If you take a sell trade below 355.4, then use 355.4 as stoploss and 346.6 as target. However if you take a buy trade in stock , then use 355.4 as stoploss and 362.65 as target.
Share price targets for United Therapeutics (UTHR)
| Target Type | Value |
| Downside Target | 342.02 |
| Upside Target | 360.46 |
| Upside Target | 372.34 |
| Upside Target | 375.61 |
| Upside Target | 377.03 |
| Upside Target | 382.61 |
| Upside Target | 383.00 |
| Upside Target | 417.82 |
Intraday share price targets for United Therapeutics (UTHR)
| Target Type | Value |
| Downside Intraday Target | 345.78 |
| Downside Intraday Target | 337.82 |
| Upside Intraday Target | 360.29 |
| Upside Intraday Target | 366.84 |
| Downside Intraday Target | 352.33 |
Weekly technical analysis of United Therapeutics (UTHR)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Thu Feb 2025 | 353.75 | 348.17 | 358.87 | 344.36 | 0.929 times |
| 31 Fri Jan 2025 | 351.17 | 369.82 | 382.61 | 349.07 | 1.167 times |
| 24 Fri Jan 2025 | 370.83 | 361.00 | 375.61 | 360.46 | 5.7 times |
| 17 Fri Jan 2025 | 358.93 | 372.34 | 372.34 | 357.25 | 0.18 times |
| 17 Fri Jan 2025 | 358.93 | 366.64 | 372.34 | 357.25 | 2.663 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of United Therapeutics (UTHR)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Thu Feb 2025 | 353.75 | 348.17 | 358.87 | 344.36 | 0.243 times |
| 31 Fri Jan 2025 | 351.17 | 352.33 | 382.61 | 349.07 | 1.33 times |
| 31 Tue Dec 2024 | 352.84 | 370.69 | 383.00 | 350.60 | 0.704 times |
| 26 Tue Nov 2024 | 377.00 | 375.78 | 417.82 | 353.65 | 0.95 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of United Therapeutics (UTHR)
Price action analysis of United Therapeutics ( (UTHR) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of United Therapeutics ( (UTHR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of United Therapeutics ( (UTHR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of United Therapeutics ( (UTHR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for United Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for United Therapeutics in short term and the sell signal is strong.
United Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for United Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of United Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 358.05 and United Therapeutics (UTHR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the United Therapeutics (UTHR) stock. Volume based technical analysis of United Therapeutics (UTHR) stock is negative.
United Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of United Therapeutics ( (UTHR) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of United Therapeutics ( (UTHR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of United Therapeutics ( (UTHR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of United Therapeutics ( (UTHR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for United Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for United Therapeutics in short term and the sell signal is strong.
United Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for United Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of United Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 358.05 and United Therapeutics (UTHR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the United Therapeutics (UTHR) stock. Volume based technical analysis of United Therapeutics (UTHR) stock is negative.
United Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.